早漏治療市場：薬剤タイプ、剤形、流通チャネル別-2025-2030年の世界予測

早漏治療市場の2023年の市場規模は35億2,000万米ドルで、2024年には38億6,000万米ドルに達すると予測され、CAGR 9.80％で成長し、2030年には67億7,000万米ドルに達すると予測されています。

早漏（PE）治療市場には、この一般的な男性性機能障害の管理または解決を目的とした幅広い製品と治療法が含まれます。射精が希望より早く起こることと定義されるPEは、苦痛や対人関係の問題につながる可能性があり、効果的な介入の必要性を強調しています。治療は、SSRIのような経口薬理学的解決策から、行動療法や局所麻酔薬まで幅広く、身体的・心理的側面の両方に対応しています。主なエンドユーザーには、ヘルスケアプロバイダーとともに、臨床的アドバイスや市販の選択肢を求めるさまざまな年齢層の男性が含まれます。この市場の主な成長促進要因には、健康意識の高まり、医薬品の進歩、男性の性の健康についてよりオープンに議論する社会へのシフトが含まれます。技術の進歩や研究開発イニシアティブは、革新的な治療法や個別化されたヘルスケア・ソリューションを開発するための肥沃な土壌を提供しています。特に、遠隔医療とeコマース・プラットフォームの出現は、治療へのアクセスを拡大し、市場プレーヤーに新たな機会をもたらしています。しかし、スティグマ（偏見）、後発地域における消費者の認識不足、治療の潜在的副作用といった制約が、引き続き成長の課題となっています。規制上のハードルや大規模な臨床試験の必要性も、新薬のイントロダクションを遅らせる要因となっています。技術革新の面では、個別化医療と、より良い診断と治療のカスタマイズのための人工知能の統合が有望視されています。非侵襲的治療や自然療法の探求は、潜在的な革新ルートを提供します。競合情勢は、既存の大手製薬会社と機動力のある新興企業の両方による活動で活気に満ちており、堅調だが入り組んだ市場特性を反映しています。事業拡大に意欲的な企業は、デジタル・プラットフォームを活用して消費者へのリーチを拡大し、長期的な成長を維持するために研究開発のための共同研究に取り組むべきです。教育的障壁に対処し、啓蒙キャンペーンを通じてこの疾患を脱染させることで、市場への浸透と消費者の関与をさらに高めることができます。

市場力学：急速に進化する早漏治療市場の主要市場インサイトを公開

早漏治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 早漏に対する各国政府の認識向上
  • 早漏の有病率の増加
  • 遠隔医療による治療の可能性
• 市場抑制要因
  • 早漏治療に関連する副作用
• 市場機会
  • 治療薬の研究開発の増加
  • 新たな診断ツール開発のための戦略的提携の増加
• 市場の課題
  • 医療従事者の不足

ポーターの5つの力早漏治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：早漏治療市場における外部からの影響の把握

外部マクロ環境要因は、早漏治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析早漏治療市場における競合情勢の把握

早漏治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス早漏治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、早漏治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨早漏治療市場における成功への道筋を描く

早漏治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 早漏に対する政府の意識向上
    • 早漏の増加
    • 遠隔医療による治療の可用性
  • 抑制要因
    • 早漏治療に関連する副作用
  • 機会
    • 治療薬の研究開発の増加
    • 新しい診断ツールの開発に向けた戦略的連携の強化
  • 課題
    • 医療従事者の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 早漏治療市場薬の種類別

• ダポキセチン
• ホスホジエステラーゼ5型（PDE5）阻害剤
• 選択的セロトニン再取り込み阻害剤
• 局所麻酔薬
• ゼルタネ

第7章 早漏治療市場：タイプ別

• 経口療法
  • 非選択的セロトニン再取り込み阻害剤
  • 選択的セロトニン再取り込み阻害剤
• 局所療法

第8章 早漏治療市場剤形別

• 錠剤
• スプレー

第9章 早漏治療市場：流通チャネル別

• 病院
• オンライン薬局
• 小売薬局

第10章 南北アメリカの早漏治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の早漏治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの早漏治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Ampio Pharmaceuticals, Inc.
• Aytu BioPharma, Inc.
• Bayer AG
• Donga Pharmaceutical Co.,Ltd.
• Eli Lilly and Company
• Emcure Pharmaceuticals
• Futura Medical PLC
• GlaxoSmithKline PLC
• Hetero Healthcare Limited
• Menarini Group
• NeuroHealing Pharmaceuticals Inc.
• Pfizer Inc.
• Veru Inc.
• Wholesome Medtech Private Limited
• zr pharma& GmbH

LIST OF FIGURES

• FIGURE 1. PREMATURE EJACULATION TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PREMATURE EJACULATION TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PREMATURE EJACULATION TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 46. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 73. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 78. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 164. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 184. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 189. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 235. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Premature Ejaculation Treatment Market was valued at USD 3.52 billion in 2023, expected to reach USD 3.86 billion in 2024, and is projected to grow at a CAGR of 9.80%, to USD 6.77 billion by 2030.

The treatment market for premature ejaculation (PE) encompasses a wide array of products and therapies aimed at managing or resolving this common male sexual dysfunction. Defined as ejaculation that occurs sooner than desired, PE can lead to distress and interpersonal issues, underlining the necessity for effective interventions. Treatments range from oral pharmacological solutions like SSRIs to behavioral therapies and topical anesthetics, catering to both physical and psychological facets. The primary end-users include men across various age groups seeking clinical advice or over-the-counter options, alongside healthcare providers. Key growth drivers in this market involve increasing health awareness, advancements in pharmaceuticals, and the societal shift towards more open discussions on male sexual health. Technological advancements and R&D initiatives provide fertile ground for developing innovative treatment modalities and personalized healthcare solutions. In particular, the advent of telemedicine and e-commerce platforms has expanded access to treatments, creating new opportunities for market players. However, limitations such as stigma, lack of consumer awareness in less developed regions, and potential side effects of treatments continue to challenge growth. Regulatory hurdles and the need for extensive clinical trials can also delay the introduction of new drugs. In terms of innovation, personalized medicine and integrating artificial intelligence for better diagnosis and therapy customization hold promise. Exploration in non-invasive treatments and natural therapies offers potential innovation routes. The competitive landscape is pulsating with activities from both established pharmaceutical giants and nimble startups, reflecting a robust but intricate market nature. Companies eager to expand should leverage digital platforms to enhance consumer reach and engage in collaborations for R&D to sustain long-term growth. Addressing educational barriers and destigmatizing the condition through awareness campaigns can further enhance market penetration and consumer engagement.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Raising governments awareness of premature ejaculation
  • Increasing prevalence of premature ejaculation
  • Availability of treatment through telehealth
• Market Restraints
  • Side effects associated with the premature ejaculation treatment
• Market Opportunities
  • Rising research & development of drugs for treatment
  • Increasing strategic collaborations for development of new diagnostic tools
• Market Challenges
  • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Premature Ejaculation Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Premature Ejaculation Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Premature Ejaculation Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Premature Ejaculation Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Premature Ejaculation Treatment Market

A detailed market share analysis in the Premature Ejaculation Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Premature Ejaculation Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Premature Ejaculation Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Premature Ejaculation Treatment Market

A strategic analysis of the Premature Ejaculation Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Premature Ejaculation Treatment Market, highlighting leading vendors and their innovative profiles. These include Ampio Pharmaceuticals, Inc., Aytu BioPharma, Inc., Bayer AG, Donga Pharmaceutical Co.,Ltd., Eli Lilly and Company, Emcure Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Hetero Healthcare Limited, Menarini Group, NeuroHealing Pharmaceuticals Inc., Pfizer Inc., Veru Inc., Wholesome Medtech Private Limited, and zr pharma& GmbH.

Market Segmentation & Coverage

This research report categorizes the Premature Ejaculation Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors, Topical Anesthetics, and Zertane.
• Based on Type, market is studied across Oral Therapies and Topical Therapies. The Oral Therapies is further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor.
• Based on Dosage Form, market is studied across Pills and Spray.
• Based on Distribution Channel, market is studied across Hospitals, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Raising governments awareness of premature ejaculation
    • 5.1.1.2. Increasing prevalence of premature ejaculation
    • 5.1.1.3. Availability of treatment through telehealth
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects associated with the premature ejaculation treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising research & development of drugs for treatment
    • 5.1.3.2. Increasing strategic collaborations for development of new diagnostic tools
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of medical professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Premature Ejaculation Treatment Market, by Drug Type

• 6.1. Introduction
• 6.2. Dapoxetine
• 6.3. Phosphodiesterase Type 5 (PDE5) Inhibitors
• 6.4. Selective Serotonin Reuptake Inhibitors
• 6.5. Topical Anesthetics
• 6.6. Zertane

7. Premature Ejaculation Treatment Market, by Type

• 7.1. Introduction
• 7.2. Oral Therapies
  • 7.2.1. Nonselective Serotonin Reuptake Inhibitor
  • 7.2.2. Selective Serotonin Reuptake Inhibitor
• 7.3. Topical Therapies

8. Premature Ejaculation Treatment Market, by Dosage Form

• 8.1. Introduction
• 8.2. Pills
• 8.3. Spray

9. Premature Ejaculation Treatment Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas Premature Ejaculation Treatment Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Premature Ejaculation Treatment Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Premature Ejaculation Treatment Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ampio Pharmaceuticals, Inc.
• 2. Aytu BioPharma, Inc.
• 3. Bayer AG
• 4. Donga Pharmaceutical Co.,Ltd.
• 5. Eli Lilly and Company
• 6. Emcure Pharmaceuticals
• 7. Futura Medical PLC
• 8. GlaxoSmithKline PLC
• 9. Hetero Healthcare Limited
• 10. Menarini Group
• 11. NeuroHealing Pharmaceuticals Inc.
• 12. Pfizer Inc.
• 13. Veru Inc.
• 14. Wholesome Medtech Private Limited
• 15. zr pharma& GmbH